Coskun Tecimer, Oncologist, Hematologist - Istanbul, Turkey

Work Experience and Educational Background:

• Specialist in Oncology Treatment

• Graduated from the Hacettepe Faculty of medicine in 1981.

• He completed a specialization in the Internal medicine department of the same university in 1987.

• Assistant professor at Inönü University Faculty of medicine department of ınternal medicine.

• Associate professor in 1993.

• Entered Marmara University's hematology department as an assistant in 1994.

• Completed his sub-specialty in hematology-oncology at Louisville University in the USA between 1996-1999.

• In 2000 was established as a professor at Kadir Has University, the medical oncology department.

• Over 17 years of clinical practice at Gayrettepe Florence Nightingale Hospital, department of hematology-oncology.

• The head of the medical oncology department at Demiroğlu Science University.

• Speaks English and Turkish.

PUBLICATIONS

• Tecimer C, Oram Y, Tecimer T. Lupus vulgaris in a patient with pulmonary tuberculosis. Cutis 1994; 53:246-8.

• Tecimer C, Yam LT. Surreptitious superwarfarin poisoning with brodifacoum. Southern Medical Journal 1997; 90:1053-5.

• Tecimer C, Loy BA, Martin AW. Acute myeloblastic leukemia (M0) with an unusual chromosomal abnormality: Translocation (1;14) (p13;q32). Cancer Genetics and Cytogenetics 1999; 111:175-7.

• Tecimer C, Doering D, Abdulhay G, Goldsmith J, Meyer JS, Wittliff JL. Clinical relevance of urokinase-type plasminogen activator, its receptor and inhibitor type 1 in ovarian cancer. International Journal of Gynecological Cancer 2000; 10:372-81.

• Tecimer C, Doering D, Abdulhay G, Goldsmith J, Meyer JS, Wittliff JL. Clinical relevance of urokinase-type plasminogen activator, its receptor and inhibitor type 1 in endometrial cancer. Gynecologic Oncology 2001; 80:48-55.

• Alço G, İğdem Ş, Dinçer M, Tecimer C, Şentürk R, Vural M, Okkan S. Gemcitabine induced radiation recall myositis: Report of two cases. International Journal of Hematology and Oncology 2009; 19: 249-253.

• Akun E, Okutur K, Seber S, Korkmaz T, Aydın K, Bozkurt M, Namal E, Hasbal B, Tecimer C, Demir G. Safety and tolerability of first-line bevacizumab in metastatic colorectal cancer. Journal of Balkan Union of Oncology 2012; 17: 669-76.

• Pilancı KN, Elbüken F, Ordu Ç, Köksal G, Tekelioğlu MH, Okutur K, Göksel S, Köksal Ü, Akçal T, Tecimer C. A case of sunitinib induced hyperammonemic encephalopathy and hypothyroidism in metastatic renal cell carcinoma. American Journal of Theapeutics (in press)